Whalesbook
Nectar Lifesciences Limited has divested its entire business related to manufacturing, distribution, marketing, and sale of active pharmaceutical ingredients (API) and formulations, along with its menthol business assets, to Ceph Lifesciences Private Limited. The transaction was conducted as a slump sale on a going concern basis. Khaitan & Co advised Nectar Lifesciences on the legal aspects of these significant deals.